Research article

Evolution of breast cancer management in Ireland: a decade of change

Helen M Heneghan¹ , Ruth S Prichard¹ , Amanda Devaney¹ , Karl J Sweeney² , C Malone¹ , Ray McLaughlin¹ and Michael J Kerin¹

¹Department of Surgery, National University of Ireland Galway, Ireland

²National Breast Cancer Screening Programme, Galway University Hospital, Galway, Ireland

author email corresponding author email

BMC Surgery 2009, 9:15doi:10.1186/1471-2482-9-15

Published:	18 September 2009

Abstract

Background

Over the last decade there has been a paradigm shift in the management of breast cancer, subsequent to revised surgical oncology guidelines and consensus statements which were derived in light of landmark breast cancer clinical trials conducted throughout the latter part of the 20th century. However the sheer impact of this paradigm shift upon all modalities of treatment, and the current trends in management of the disease, are largely unknown. We aimed to assess the changing practices of breast cancer management over the last decade within a specialist tertiary referral Breast Cancer Centre.

Methods

Comparative analysis of all aspects of the management of breast cancer patients, who presented to a tertiary referral Breast Cancer Centre in 1995/1996 and 2005/2006, was undertaken and measured against The European Society for Surgical Oncology guidelines for the surgical management of mammographically detected lesions [1998].

Results

613 patients' case profiles were analysed. Over the last decade we observed a dramatic increase in incidence of breast cancer [>100%], a move to less invasive diagnostic and surgical therapeutic techniques, as well as increased use of adjuvant therapies. We also witnessed the introduction of immediate breast reconstruction as part of routine practice

Conclusion

We demonstrate that radical changes have occurred in the management of breast cancer in the last decade, in keeping with international guidelines. It remains incumbent upon us to continue to adapt our practice patterns in light of emerging knowledge and best evidence.